Exploring the Bullish Trends on Moderna's Stock
Investors with considerable capital have shown a markedly bullish outlook on Moderna.
Analyzing the options activity for Moderna (MRNA), we found 15 distinct trades. Delving into the details of each trade reveals that 60% of investors were operating with bullish sentiments, while the remaining 40% were bearish.
Among these trades, there were 10 puts, amounting to $1,639,604, alongside 5 calls, totaling $239,740.
Projected Price Targets for Moderna
Considering the volume and open interest associated with these contracts, it appears that significant investors have been eyeing a price range from $60.00 to $120.00 for Moderna in recent months.
Volume and Open Interest Trends
As of the latest trading session, the average open interest for Moderna options stands at approximately 1,500.79, with total volume hitting 847.00. A detailed chart illustrates the trends in call and put option volume as well as open interest related to high-value trades for Moderna within the $60.00 to $120.00 strike price interval over the past 30 days.
Moderna Call and Put Volume: 30-Day Overview
This section observes the patterns of call and put volume, significant for gauging investor sentiment and imminent market movements.
Largest Options Trades Observed
Detailed analysis of the largest options trades reveals varying investor approaches:
- MRNA: PUT - SWEEP, BEARISH, Exp. Date: 06/20/25, Ask: $62.1, Bid: $60.95, Total Trade Price: $993.6K
- MRNA: PUT - TRADE, BULLISH, Exp. Date: 09/19/25, Ask: $13.55, Bid: $13.35, Total Trade Price: $201.0K
- MRNA: PUT - SWEEP, BEARISH, Exp. Date: 03/21/25, Ask: $20.8, Bid: $20.65, Total Trade Price: $122.7K
- MRNA: PUT - SWEEP, BULLISH, Exp. Date: 01/17/25, Ask: $27.0, Bid: $26.95, Total Trade Price: $102.4K
- MRNA: CALL - SWEEP, BULLISH, Exp. Date: 09/19/25, Ask: $5.35, Bid: $5.2, Total Trade Price: $90.4K
About Moderna
Founded in 2010, Moderna has become a leading commercial-stage biotechnology firm. The company’s mRNA technology found rapid validation in the wake of its COVID-19 vaccine, approved for emergency use in December 2020. Currently, Moderna boasts 40 mRNA candidates in various stages of clinical development across diverse health areas, such as infectious diseases, oncology, cardiovascular issues, and rare genetic disorders.
Following the examination of the options activities tied to Moderna, let’s shift our attention to the company’s current market position.
Current Market Position of Moderna
- The stock is currently trading with a volume of 1,302,422 and has seen an increase of 0.96%, now priced at $58.95.
- Relative Strength Index (RSI) indicators suggest that the stock may be oversold at this time.
- Investors are eagerly anticipating the upcoming earnings report in about 22 days.
Insights from Market Experts on Moderna
In the last month, a total of 5 investment experts have shared their evaluations on Moderna, projecting an average price target of $89.8.
What Analysts Are Saying
- An analyst from TD Cowen maintains a Hold rating, setting a target price of $60.
- Jefferies has adjusted their stance to Hold with a target of $65.
- B of A Securities continues to uphold a Neutral rating, projecting a target of $110.
- RBC Capital keeps a Sector Perform rating with a target of $75.
- Goldman Sachs holds a Buy rating, setting an ambitious target price of $139.
Options trading carries inherent risks compared to straightforward stock trading, yet they also offer higher potential rewards. Experienced options traders mitigate risks by continually educating themselves, strategically entering and exiting trades, utilizing multiple indicators, and closely monitoring market conditions.
For those keen on staying updated on the latest trades in Moderna options, real-time alerts are available through various financial services.
Frequently Asked Questions
What is the sentiment around Moderna's stock?
Recent options trading indicates a bullish sentiment among most investors, with 60% opening trades expecting price increases.
What are the projected price targets for Moderna?
Investors are targeting a price range between $60.00 and $120.00 based on the latest analysis of trading activities.
Who are the notable analysts tracking Moderna?
Five analysts have issued ratings on Moderna recently, with targets ranging from $60 to $139.
What should investors know about options trading with Moderna?
Options trading is riskier than regular stock trading, but it also has greater profit potential if managed carefully.
How has Moderna performed recently in the market?
Moderna has shown a slight increase of 0.96%, currently priced at $58.95 amid a trading volume of over 1.3 million shares.
